Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
MGRX: Mangoceuticals, Inc. Stock Analysis | finqOS
Healthcare · Medical - Healthcare Information Services
The Story
MGRX
The Story
MGRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-15.8% / yr
Operating margin
-4203.8%
ROIC
-126.6%
Financially safe
Stretched
Debt / equity
0.02×
Interest coverage
-44.2×
Current ratio
0.29×
Mangoceuticals, Inc.
MGRX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Mangoceuticals, Inc.
MGRX
NASDAQ
·
USD
·
Closed
$0.56
+89.75%
$0.56
+$0.26 (89.75%)
52W Range
15th
pctl
Volume
405.53×
avg
Mkt Cap
5.65M
USD
P/E
-0.3
TTM
Div Yield
–
ann
52W Range
15th
pctl
Volume
405.53×
avg
Market Cap
5.65M
USD
P/E Ratio
-0.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings